APA (7th ed.) Citation

M, S., H, K., F, F., SE, B., LME, J., BC, C., . . . WW, O. (2020). Bempegaldesleukin selectively depletes intratumoral Tregs and potentiates T cell-mediated cancer therapy. Nature communications, 11(1), 661. https://doi.org/10.1038/s41467-020-14471-1

Chicago Style (17th ed.) Citation

M, Sharma, et al. "Bempegaldesleukin Selectively Depletes Intratumoral Tregs and Potentiates T Cell-mediated Cancer Therapy." Nature Communications 11, no. 1 (2020): 661. https://doi.org/10.1038/s41467-020-14471-1.

MLA (9th ed.) Citation

M, Sharma, et al. "Bempegaldesleukin Selectively Depletes Intratumoral Tregs and Potentiates T Cell-mediated Cancer Therapy." Nature Communications, vol. 11, no. 1, 2020, p. 661, https://doi.org/10.1038/s41467-020-14471-1.